Global Radiation Therapy Systems Market Expected to Reach $5.6B by 2020
Although immunotherapy and other cutting-edge technologies have dominated the spotlight in cancer treatment over the last several years, the use of radiation therapy is rapidly increasing as physicians look to this non-invasive, cost-effective treatment to address a broad and growing number of cancers. Valued at nearly $4.3 billion in 2015, the global radiation therapy market is growing at a CAGR of 5.5%, and is projected to reach $5.6 billion by 2020, according to a recent report from Medtech Insight.
You may also be interested in...
Physicians developing a promising technique for noninvasive cardiac radioablation for ventricular tachycardia are working with US FDA to develop a large multicenter trial of their technique following the success of a five-patient case-series and an 18-patient prospective study.
In the billion dollar market for radiotherapy products, pencil beam proton therapy could potentially revolutionize cancer care but the technology is very expensive, and it remains to be seen how many medical institutions in the US and worldwide will be interested in adopting the large systems, which require years to construct. Scripps Proton Therapy Center medical director Carl Rossi, MD, speaks about the benefits of proton therapy compared with other types of radiation therapy.
Acoramidis, AstraZeneca/BridgeBio Pharma's investigational treatment for patients with transthyretin amyloid cardiomyopathy, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.